| ID: | 73 | |
|---|---|---|
| Name: | Compound 73 | |
| Description: | Original numeration in publication: 27e | |
| Labels: | Training_set, Quinoxalines | |
| CAS: | ||
| InChi Code: | InChI=1S/C24H19N5O5/c1-15-24(32)28(21-5-3-2-4-20(21)25-15)14-22(30)26-17-8-6-16(7-9-17)23(31)27-18-10-12-19(13-11-18)29(33)34/h2-13H,14H2,1H3,(H,26,30)(H,27,31) |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 7.66 |
Alanazi, M. M.; Eissa, I. H.; Alsaif, N. A. a. O., A. J.; Alanazi, W. A.; Alasmari, A. F. a. A., H.; Elkady, H.; Elwan, A. Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. J. Enzyme Inhib. Med. Chem. 2021, 36, 1760–1782. https://doi.org/10.1080/14756366.2021.1956488 |
| 7.20245 |
Eq1: VEGFR-2 inhibition (Data used to train model) |